Ott Myriam, Santner Tobias, Singh Neeraj, Bauland Friederike, Köppl Daniel, Gaudl Alexander, Geistanger Andrea, Ceglarek Uta, Rauh Manfred, Geletneky Christian, Taibon Judith
Roche Diagnostics GmbH, Penzberg, Germany.
Chrestos Concept GmbH & Co. KG, Essen, Germany.
Clin Chem Lab Med. 2025 May 26. doi: 10.1515/cclm-2024-1255.
A new candidate isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based reference measurement procedure (RMP) has been developed for the accurate and precise quantification of 17β-estradiol (E2) in human serum and plasma covering a measurement range from 0.400 to 5,000 pg/mL (1.47-18,357 pmol/L). To address this broad range, two separate methods were created: a high sensitivity (HS) method for concentrations between 0.400 and 5.00 pg/mL (1.47-18.4 pmol/L) and a standard range (SR) method for concentrations between 5.00 and 5,000 pg/mL (18.4-18,357 pmol/L).
As the primary reference material, E2 (CRM 6004-a) from the National Metrology Institute of Japan was used to ensure traceability to the international system (SI). A two-dimensional heart-cut LC approach was utilized for LC-MS/MS analysis, employing a supported liquid extraction sample preparation protocol for the SR method and a liquid-liquid extraction protocol followed by derivatization for the HS method. Assay validation was conducted following current guidelines. Selectivity and specificity were assessed using spiked serum samples, while potential matrix effects were evaluated through a post-column infusion experiment and comparison of standard line slopes. Precision, accuracy, and trueness were determined using an extensive 5-day protocol. Standard measurement uncertainty was evaluated according to the Guide to the Expression of Uncertainty in Measurement (GUM), with three individual sample preparations performed on at least two different days. Equivalence with higher-order RMPs was demonstrated through participation in the CDC Steroid Hormones Standardization (HoSt) program.
The RMP enabled the quantification of E2 within the range of 0.400-5,000 pg/mL (1.47-18,357 pmol/L), demonstrating no interference from structurally related compounds and no evidence of matrix effects. The relative mean bias of the SR method ranged from -2.4 to 1.9 % across all levels, including secondary reference materials and spiked samples, whereas the HS method exhibited a mean bias ranging from -3.0 to 2.9 %. Expanded measurement uncertainties (k=2) for target value assignment ranged from 1.7 to 4.4 % for the SR method and were found to be ≤6.1 % for the HS method. The method's transferability was demonstrated in a comparison study at a second laboratory. Additionally, the candidate RMP exhibited excellent correlation and equivalence to JCTLM-listed RMPs through the CDC HoSt program.
In summary, the ID-LC-MS/MS-based RMP accurately quantifies E2. Its robust performance makes it suitable for standardizing routine assays and measuring individual patient samples, ensuring traceability.
已开发出一种基于同位素稀释-液相色谱-串联质谱(ID-LC-MS/MS)的新型参考测量程序(RMP),用于准确、精确地定量测定人血清和血浆中17β-雌二醇(E2),测量范围为0.400至5,000 pg/mL(1.47 - 18,357 pmol/L)。为满足这一较宽范围的测量需求,创建了两种独立的方法:一种高灵敏度(HS)方法用于测定浓度在0.400至5.00 pg/mL(1.47 - 18.4 pmol/L)之间的E2,另一种标准范围(SR)方法用于测定浓度在5.00至5,000 pg/mL(18.4 - 18,357 pmol/L)之间的E2。
使用日本国家计量院的E2(CRM 6004-a)作为主要参考物质,以确保可溯源至国际单位制(SI)。采用二维中心切割液相色谱法进行LC-MS/MS分析,SR方法采用支撑液液萃取样品制备方案,HS方法采用液液萃取方案随后进行衍生化处理。按照现行指南进行分析方法验证。使用加标血清样品评估选择性和特异性,通过柱后注入实验和标准曲线斜率比较评估潜在的基质效应。使用为期5天的广泛方案确定精密度、准确度和真实性。根据《测量不确定度表示指南》(GUM)评估标准测量不确定度,至少在两个不同日期对三个独立的样品制备进行评估。通过参与美国疾病控制与预防中心(CDC)类固醇激素标准化(HoSt)计划,证明了与更高阶RMP的等效性。
该RMP能够在0.400 - 5,000 pg/mL(1.47 - 18,357 pmol/L)范围内定量测定E2,表明无结构相关化合物的干扰,也没有基质效应的证据。SR方法在所有水平(包括二级参考物质和加标样品)上的相对平均偏差范围为 -2.4%至1.9%,而HS方法的平均偏差范围为 -3.0%至2.9%。SR方法目标值赋值的扩展测量不确定度(k = 2)范围为1.7%至4.4%,HS方法的扩展测量不确定度≤6.1%。在第二个实验室进行的比较研究中证明了该方法的可转移性。此外,通过CDC HoSt计划,候选RMP与JCTLM列出的RMP表现出极好的相关性和等效性。
总之,基于ID-LC-MS/MS的RMP能够准确地定量测定E2。其稳健的性能使其适用于常规检测的标准化和个体患者样本的测量,确保了可溯源性。